Taro Tobo

1.4k total citations
34 papers, 747 citations indexed

About

Taro Tobo is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Taro Tobo has authored 34 papers receiving a total of 747 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 11 papers in Oncology and 11 papers in Cancer Research. Recurrent topics in Taro Tobo's work include RNA modifications and cancer (6 papers), Cancer-related molecular mechanisms research (4 papers) and Cancer Genomics and Diagnostics (4 papers). Taro Tobo is often cited by papers focused on RNA modifications and cancer (6 papers), Cancer-related molecular mechanisms research (4 papers) and Cancer Genomics and Diagnostics (4 papers). Taro Tobo collaborates with scholars based in Japan, United States and Singapore. Taro Tobo's co-authors include Koshi Mimori, Takaaki Masuda, Hidetoshi Eguchi, Kuniaki Sato, Shuhei Ito, Qingjiang Hu, Sho Nambara, Yosuke Kuroda, Tomohiro Iguchi and Hidetaka Yamamoto and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Cancer Research.

In The Last Decade

Taro Tobo

30 papers receiving 737 citations

Peers

Taro Tobo

PRM

ONCOL

GASTR

Michaela A. Ihle Germany

Nina Korzeniewski Germany

Qingfeng Ni China

Derek Yau China

Kristen E. Muller United States

Masanobu Kusano Japan

Caterina Vicentini Italy

Karine Pallier France

Wenguang He China

Jiabo Di China

Michaela A. Ihle Germany

Taro Tobo

310 ×0.7

177 ×0.6

283 ×1.6

PRM

259 ×1.5

ONCOL

87 ×0.7

GASTR

Citations per year, relative to Taro Tobo Taro Tobo (= 1×) peers Michaela A. Ihle

Countries citing papers authored by Taro Tobo

Since Specialization

Citations

This map shows the geographic impact of Taro Tobo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Taro Tobo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Taro Tobo more than expected).

Fields of papers citing papers by Taro Tobo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Taro Tobo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Taro Tobo. The network helps show where Taro Tobo may publish in the future.

Co-authorship network of co-authors of Taro Tobo

This figure shows the co-authorship network connecting the top 25 collaborators of Taro Tobo. A scholar is included among the top collaborators of Taro Tobo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Taro Tobo. Taro Tobo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ohmura, Hirofumi, Taro Tobo, Yukio Ando, et al.. (2024). Case report: A rare case of triple negative breast cancer with development of acute pancreatitis due to dexamethasone during adjuvant chemotherapy. Frontiers in Oncology. 14. 1340419–1340419.

Ohmura, Hirofumi, Taro Tobo, Koshi Mimori, Eishi Baba, & Takahiko Horiuchi. (2023). Trousseau’s Syndrome with Advanced Neuroendocrine Carcinoma of Colon: A Case Report. SHILAP Revista de lepidopterología. 16(1). 490–496. 1 indexed citations

Masuda, Takaaki, Taro Tobo, Yuta Kobayashi, et al.. (2022). Transducin Beta-Like 2 is a Potential Driver Gene that Adapts to Endoplasmic Reticulum Stress to Promote Tumor Growth of Lung Adenocarcinoma. SSRN Electronic Journal.

Mochizuki, Kenichi, Shin‐ei Kudo, Kazuki Kato, et al.. (2022). Molecular and clinicopathological differences between depressed and protruded T2 colorectal cancer. PLoS ONE. 17(10). e0273566–e0273566. 1 indexed citations

Hu, Qingjiang, Takaaki Masuda, Kuniaki Sato, et al.. (2021). Oxysterol binding protein-like 3 (OSBPL3) is a novel driver gene that promotes tumor growth in part through R-Ras/Akt signaling in gastric cancer. Scientific Reports. 11(1). 19178–19178. 16 indexed citations

Takahashi, Junichi, Takaaki Masuda, Taro Tobo, et al.. (2021). Fanconi Anemia Complementation Group E, a DNA Repair-Related Gene, Is a Potential Marker of Poor Prognosis in Hepatocellular Carcinoma. Oncology. 100(2). 101–113. 4 indexed citations

Masuda, Takaaki, Shuhei Ito, Taro Tobo, et al.. (2020). Circulating PD-1 mRNA in Peripheral Blood is a Potential Biomarker for Predicting Survival of Breast Cancer Patients. Annals of Surgical Oncology. 27(10). 4035–4043. 11 indexed citations

Masuda, Takaaki, Junichi Takahashi, Taro Tobo, et al.. (2020). KIF15 Expression in Tumor-associated Monocytes Is a Prognostic Biomarker in Hepatocellular Carcinoma. Cancer Genomics & Proteomics. 17(2). 141–149. 18 indexed citations

Ito, Shuhei, Takaaki Masuda, Qingjiang Hu, et al.. (2020). Prognostic Significance of PD-1, PD-L1 and CD8 Gene Expression Levels in Gastric Cancer. Oncology. 98(7). 501–511. 14 indexed citations

10.

Hu, Qingjiang, Takaaki Masuda, Taro Tobo, et al.. (2020). Potential association of LOXL1 with peritoneal dissemination in gastric cancer possibly via promotion of EMT. PLoS ONE. 15(10). e0241140–e0241140. 17 indexed citations

11.

Sato, Kuniaki, Takaaki Masuda, Qingjiang Hu, et al.. (2019). Novel oncogene 5MP1 reprograms c-Myc translation initiation to drive malignant phenotypes in colorectal cancer. EBioMedicine. 44. 387–402. 44 indexed citations

12.

Iguchi, Tomohiro, Masami Ueda, Takaaki Masuda, et al.. (2018). Identification of UHRF2 as a Negative Regulator of Epithelial-Mesenchymal Transition and Its Clinical Significance in Esophageal Squamous Cell Carcinoma. Oncology. 95(3). 179–187. 18 indexed citations

13.

Wakiyama, Hiroaki, Takaaki Masuda, Qingjiang Hu, et al.. (2018). Cytolytic Activity (CYT) Score Is a Prognostic Biomarker Reflecting Host Immune Status in Hepatocellular Carcinoma (HCC). Anticancer Research. 38(12). 6631–6638. 37 indexed citations

14.

Sato, Kuniaki, Atsushi Niida, Takaaki Masuda, et al.. (2018). Multiregion Genomic Analysis of Serially Transplanted Patient-derived Xenograft Tumors. Cancer Genomics & Proteomics. 16(1). 21–27. 10 indexed citations

15.

Sato, Kuniaki, Takaaki Masuda, Qingjiang Hu, et al.. (2017). Phosphoserine Phosphatase Is a Novel Prognostic Biomarker on Chromosome 7 in Colorectal Cancer. Anticancer Research. 37(5). 2365–2371. 39 indexed citations

16.

Hu, Qingjiang, Takaaki Masuda, Kuniaki Sato, et al.. (2017). Identification of ARL4C as a Peritoneal Dissemination-Associated Gene and Its Clinical Significance in Gastric Cancer. Annals of Surgical Oncology. 25(3). 745–753. 43 indexed citations

17.

Nambara, Sho, Takaaki Masuda, Taro Tobo, et al.. (2017). Clinical significance of ZNF750 gene expression, a novel tumor suppressor gene, in esophageal squamous cell carcinoma. Oncology Letters. 14(2). 1795–1801. 11 indexed citations

18.

Sakamoto, Katsumi, Masakazu Hirakawa, Koshi Mimori, et al.. (2014). A case of gastric plexiform fibromyxoma: radiological and pathological findings. Japanese Journal of Radiology. 32(7). 431–436. 18 indexed citations

19.

Tobo, Taro, Minako Hirahashi, Takashi Yao, Shinichi Aishima, & Yoshinao Oda. (2012). Ezrin expression and its phosphorylation in gastric carcinoma with lymphoid stroma and Epstein-Barr virus infection. Molecular and Clinical Oncology. 1(2). 220–224. 8 indexed citations

20.

Yamamoto, Hidetaka, Taro Tobo, Masakazu Imamura, et al.. (2008). Neurofibromatosis type 1-related gastrointestinal stromal tumors: a special reference to loss of heterozygosity at 14q and 22q. Journal of Cancer Research and Clinical Oncology. 135(6). 791–798. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact